EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis: Frenemy of Radiotherapy

Lisa Kerkhove iD, Febe Geirnaert iD, Inès Dufait iD, Mark De Ridder iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25073641 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lisa Kerkhove und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. Hauptthemen laut MEDLINE: Ferroptosis, Radiation Oncology, Radiation-Sensitizing Agents, Regulated Cell Death. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kom Op Tegen Kanker, Vrije Universiteit Brussel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, it was established that ferroptosis, a type of iron-dependent regulated cell death, plays a prominent role in radiotherapy-triggered cell death. Accordingly, ferroptosis inducers attracted a lot of interest as potential radio-synergizing drugs, ultimately enhancing radioresponses and patient outcomes. Nevertheless, the tumor microenvironment seems to have a major impact on ferroptosis induction. The influence of hypoxic conditions is an area of interest, as it remains the principal hurdle in the field of radiotherapy. In this review, we focus on the implications of hypoxic conditions on ferroptosis, contemplating the plausibility of using ferroptosis inducers as clinical radiosensitizers. Furthermore, we dive into the prospects of drug repurposing in the domain of ferroptosis inducers and radiosensitizers. Lastly, the potential adverse effects of ferroptosis inducers on normal tissue were discussed in detail. This review will provide an important framework for subsequent ferroptosis research, ascertaining the feasibility of ferroptosis inducers as clinical radiosensitizers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisRadiation OncologyRadiation-Sensitizing AgentsRegulated Cell DeathHumansCell DeathHypoxia

Stichwörter der Autor:innen

drug repurposingferroptosisnormal tissue toxicityradiotherapy

Substanzen

Radiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.

ORCID-Profile: Lisa Kerkhove, Febe Geirnaert, Inès Dufait, Mark De Ridder

Förderung

  • Kom Op Tegen Kanker
  • Vrije Universiteit Brussel

Zitieren

APA

Kerkhove, L., Geirnaert, F., Dufait, I., & De Ridder, M. (2024). Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073641

Vancouver

Kerkhove L, Geirnaert F, Dufait I, De Ridder M. Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073641

BibTeX
@article{Kerkhove2024,
  author = {Kerkhove, Lisa and Geirnaert, Febe and Dufait, Inès and De Ridder, Mark},
  title = {Ferroptosis: Frenemy of Radiotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25073641}
}
Kostenlos starten →